Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1065 results found. Search for [ generic drug ]

Results 1 to 21 of 1065
Joe C Mathew and Nidhi Singal
New Delhi, April 14, 2021
The Production Linked Incentive Scheme aims to build an Indian manufacturing base across 13 key sectors. What works. What doesn't


PB Jayakumar
March 31, 2021
Hemmo is one of the few pure-play synthetic peptide API manufacturers in the global marketplace. It has R&D capabilities and a world-class GMP manufacturing facility at Thurbhe in Navi Mumbai


BusinessToday.In
March 30, 2021
Biocon share price rose as much as 2.71 per cent to hit intraday high of Rs 406 on the BSE after the biopharma company signed pact with Libbs Farmaceutica to launch generic formulations in Brazil


BusinessToday.In
March 25, 2021
Shares of Craftsman Automation, Anupam Rasayan, Laxmi Organic Industries, Adani Green, Cadila, TVS Motors, Bank of India, Jubilant FoodWorks will be in focus in Thursday's trading session


BusinessToday.In
March 24, 2021
Stock Market News Update Today: The BSE Sensex witnessed broader-based selling with 28 out of 30 BSE index heavyweights ending in red amid fear that second and third wave infections in India are bound to hamper economic recovery


BusinessToday.In
March 23, 2021
Stock Market News Update Today: UltraTech Cement, Titan Company, ICICI Bank, IndusInd Bank, Axis Bank were among top gainers, while ONGC, Power Grid Corporation of India, ITC, NTPC, HDFC were among top losers


BusinessToday.In
March 5, 2021
Shares of Wipro, Heranba Industries, Indiabulls Housing, Unichem Labs, Jagran Prakashan and others will be in focus in Friday's trading session


PTI
March 2, 2021
The company has launched a generic product in the market after having received approval from the US and Drug Administration (U.S.FDA) earlier.


PTI
March 2, 2021
The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline's Imitrex Nasal Spray


PB Jayakumar
February 25, 2021
To reach that target from the current $42 billion, the Indian pharmaceutical industry will require to double the last decade's growth rate of 6% to 12%


BusinessToday.In
February 24, 2021
Stock Market Updates Today: Sectorally, except for IT and pharma index, all the other indices ended with decent gains. Private, PSU Bank and financial indices closed 3% higher today.


BusinessToday.In
February 24, 2021
Stocks to watch today on February 24: Coal India, Pfizer, SBI Cards, Tata Power, NTPC, UPL among others are the top stocks to watch out for in Wednesday's trading session


PTI
February 23, 2021
\"Because of the anti-China sentiment, most of the companies are working towards de-risking themselves in terms of making it clear that their supply chain linkages with China are limited,\" says Gaurav Suchak, supply head of Cadila


BusinessToday.In
February 19, 2021
The pharma share touched an intraday high of Rs 329.25, rising 7.74% on BSE


BusinessToday.In
February 19, 2021
Stock Market News Updates Today: Bajaj Finserv, IndusInd Bank, RIL, Kotak Bank were among the top gainers today, while NTPC, PowerGrid, Asian Paints, ICICI Bank, Tata Motors were among the top losers


BusinessToday.In
February 11, 2021
Stock Market News Updates Today: RIL, Bajaj twins, Airtel were among the top gainers while, Nestle, TCS, Axis Bank, L&T traded as the top losers


BusinessToday.In
February 7, 2021
As per the USFDA report, the affected lot of the intramuscular injections was manufactured by the drug maker in India and distributed in the US by Princeton, New Jersey-based Sun Pharmaceutical Industries Inc.


PTI
February 7, 2021
The affected lot of the intramuscular injections was manufactured by the drug maker in India and distributed in the US by Princeton, New Jersey-based Sun Pharmaceutical Industries Inc


BusinessToday.In
February 3, 2021
India Stock Market News Updates Today: IndusInd Bank, followed by Dr Reddy's, PowerGrid, Tech Mahindra, M&M, Sun Pharma and Axis Bank were among the top gainers. On the other hand, Maruti, Kotak Bank, SBI and UltraTech Cement were among the losers


Vamsi Maddipatla
February 1, 2021
With a cohesive effort from both public and private players, the Indian bio-pharma industry has the potential to unlock tremendous growth over the next few years


PAGES 1 OF 54  12345